TWI757830B - Use of glycyrrhiza extract in preparation of medicament for treating glottic insufficiency with inhalation - Google Patents

Use of glycyrrhiza extract in preparation of medicament for treating glottic insufficiency with inhalation Download PDF

Info

Publication number
TWI757830B
TWI757830B TW109127683A TW109127683A TWI757830B TW I757830 B TWI757830 B TW I757830B TW 109127683 A TW109127683 A TW 109127683A TW 109127683 A TW109127683 A TW 109127683A TW I757830 B TWI757830 B TW I757830B
Authority
TW
Taiwan
Prior art keywords
licorice extract
licorice
extract
treatment
vocal cord
Prior art date
Application number
TW109127683A
Other languages
Chinese (zh)
Other versions
TW202206091A (en
Inventor
徐正明
李懿芸
吳清源
林育昰
張耕閤
楊曜旭
蔡明劭
葉瑞銘
楊佩蓉
Original Assignee
長庚醫療財團法人嘉義長庚紀念醫院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 長庚醫療財團法人嘉義長庚紀念醫院 filed Critical 長庚醫療財團法人嘉義長庚紀念醫院
Priority to TW109127683A priority Critical patent/TWI757830B/en
Publication of TW202206091A publication Critical patent/TW202206091A/en
Application granted granted Critical
Publication of TWI757830B publication Critical patent/TWI757830B/en

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The use of Glycyrrhiza extract in preparation of medicine for treating glottis insufficiency with inhalation is provided. The use includes: providing a Glycyrrhiza extract, and laryngeal administrating the solution to a subject in need thereof. The advantages of using the Glycyrrhiza extract include reduced side effects compared to Western medical treatment, improving patient compliance and significantly improving hoarse symptom compared to the currently available treatment.

Description

甘草萃取液用於製備治療聲帶閉鎖不全之藥物的用途 Use of licorice extract for preparing medicine for treating vocal cord insufficiency

本發明係關於一種甘草萃取液及其用於製備治療聲帶閉鎖不全之藥物的用途,特別係關於一種能夠藉由薰蒸方式使用之甘草萃取液來治療因聲帶麻痺或聲帶萎縮所造成之聲門閉鎖不全者。 The present invention relates to a licorice extract and its use for preparing a medicine for treating insufficiency of vocal cords, in particular to a licorice extract that can be used by fumigation to treat glottis atresia caused by vocal cord paralysis or vocal cord atrophy Incomplete.

聲帶閉鎖不全係由聲帶不完全閉合所導致,其原因包括聲帶活動性和聲帶黏膜性病變。聲帶活動性病變包括神經肌肉和關節脫位引起的單側聲帶麻痹,而聲帶黏膜性病變則包括聲帶缺損、疤痕、萎縮和聲帶溝,兩者都會造成聲門無法閉合,統稱為聲帶閉鎖不全。 Vocal cord insufficiency is caused by incomplete closure of the vocal cords, including vocal cord mobility and mucosal lesions of the vocal cords. Vocal cord activity lesions include unilateral vocal cord paralysis caused by neuromuscular and joint dislocation, while vocal cord mucosal lesions include vocal cord defects, scarring, atrophy, and vocal cord grooves, both of which can cause the glottis to fail to close, collectively referred to as vocal cord insufficiency.

單側聲帶麻痹一般係由於外科手術、腫瘤或中風等造成,其症狀包括沙啞或是伴隨吞嚥困難,可能導致肺炎,並可能危及生命;目前對單側聲帶麻痹的治療包括語言治療、聲帶注射自體脂肪或是玻尿酸,以及甲狀軟骨成形手術等。 Unilateral vocal cord paralysis is generally caused by surgery, tumor, or stroke. Symptoms include hoarseness or accompanying dysphagia, which may lead to pneumonia and may be life-threatening. Current treatments for unilateral vocal cord paralysis include speech therapy, vocal cord injection, and Body fat or hyaluronic acid, and thyroid cartilage surgery, etc.

至於聲帶萎縮則是因為聲帶本身先天或後天的膠原蛋白減少而造成聲帶體積不足,以至於不夠維持聲門的關閉力量,導致發聲容易造成無力 或是嚴重情況時的沙啞。而後天的膠原蛋白減少一般係聲帶老化或是過度使用所造成,其治療方式也同樣可使用語言治療、聲帶注射自體脂肪或是玻尿酸,以及甲狀軟骨成形手術。 As for the atrophy of the vocal cords, it is because the congenital or acquired collagen of the vocal cords itself is reduced, resulting in insufficient volume of the vocal cords, so that it is not enough to maintain the closing force of the glottis, resulting in weakness in vocalization. Or hoarseness in severe cases. Acquired collagen reduction is generally caused by aging or overuse of the vocal cords. The treatment methods can also use speech therapy, vocal cord injection of autologous fat or hyaluronic acid, and thyroid cartilage surgery.

聲門閉鎖不全一直是每位耳鼻喉科醫師面臨的挑戰,上述三種治療方法中,語言治療的效果不一,聲帶注射則需要自費或是時間無法長久,而甲狀軟骨成形手術則會有手術的風險及併發症。 Insufficiency of the glottis has always been a challenge faced by every otolaryngologist. Among the above three treatment methods, speech therapy has different effects. Vocal cord injections require their own expenses or cannot last for a long time, and thyroplasty surgery requires surgery. Risks and complications.

因此,有必要提供一種減少副作用且確實能改善及/或治療聲門閉鎖不全之藥物及其用途。 Therefore, it is necessary to provide a medicament that reduces side effects and can indeed improve and/or treat glottic insufficiency and its use.

鑑於上述問題,本發明係提供一種甘草萃取液,其活性成分係為甘草,其為純中藥之成分。甘草萃取液中不含西藥及類固醇,芳香清甜,不具侵入性,病患及民眾之接受度較高且藥材簡便廉價。 In view of the above problems, the present invention provides a licorice extract whose active ingredient is licorice, which is a component of pure traditional Chinese medicine. The licorice extract contains no western medicines and steroids. It is fragrant, sweet, and non-invasive. It is highly accepted by patients and the public, and the medicinal materials are simple and cheap.

根據本發明之目的,提供一種甘草萃取液用於製備治療聲帶閉鎖不全之藥物的用途,其包含提供甘草萃取液;以及藉由口或鼻吸入之薰蒸方式,施予甘草萃取液於目標物之喉部。 According to the purpose of the present invention, there is provided a use of a licorice extract for preparing a medicine for treating vocal cord insufficiency, which comprises providing a licorice extract; and applying the licorice extract to a target by fumigation by oral or nasal inhalation the throat.

本發明所提供之甘草萃取液,其係將適量之甘草以水性溶液進行煎煮萃取而獲得具有甘草活性成分萃取物之甘草萃取液。 The licorice extract provided by the present invention is obtained by decocting and extracting an appropriate amount of licorice with an aqueous solution to obtain a licorice extract having the active ingredient extract of licorice.

S10~S40:步驟 S10~S40: Steps

第1圖係為本發明之甘草萃取液的製備流程示意圖; 第2圖係為搭配甘草萃取液之中醫藥治療之聲帶萎縮患者在治療前後的VHI-10分析圖;第3圖係為搭配甘草萃取液之中醫藥治療之聲帶麻痺患者在治療前後的VHI-10分析圖;第4a圖係為聲帶麻痹患者治療前之聲帶示意圖;第4b圖係為聲帶麻痹患者治療後之聲帶示意圖。 Figure 1 is a schematic diagram of the preparation process of the licorice extract of the present invention; Figure 2 is the analysis chart of VHI-10 of patients with vocal cord atrophy treated with traditional Chinese medicine with licorice extract before and after treatment; Figure 3 is the VHI-10 of patients with vocal cord paralysis treated with traditional Chinese medicine with licorice extract before and after treatment 10. Analysis chart; Figure 4a is a schematic diagram of the vocal cords of a patient with vocal cord paralysis before treatment; Figure 4b is a schematic diagram of the vocal cords of a patient with vocal cord paralysis after treatment.

為使上述目的、技術特徵及實際實施後之效益更易於使本領域具通常知識者理解,將於下文中以實施例搭配圖式更詳細地說明。 In order to make the above-mentioned purposes, technical features and benefits after practical implementation easier for those skilled in the art to understand, the following will be described in more detail with examples and drawings.

甘草,其具有以下所述之中藥藥性:性平,味甘,歸十二經;{功能主治}補脾益氣、清熱解毒、祛痰止咳、緩急止痛、調和諸藥;主治脾胃虛弱、倦怠乏力、心悸氣短、咳嗽痰多、脘腹、四肢攣急疼痛、癰腫瘡毒、緩解藥物毒性、烈性。 Licorice has the following Chinese medicinal properties: flat in nature, sweet in taste, and returns to the twelve meridians; {function cures mainly} invigorating the spleen and replenishing qi, clearing away heat and detoxifying, eliminating phlegm and relieving cough, relieving acute pain and reconciling various medicines; treating spleen and stomach weakness, fatigue Fatigue, palpitations, shortness of breath, cough and phlegm, epigastric pain, contracture and pain of limbs, carbuncle and sore, relieving drug toxicity, strong.

本發明藉由薰蒸甘草萃取液之方式對聲門閉鎖不全之患者進行治療,改善聲音沙啞症狀以達到更佳之治療效果。 The present invention treats patients with insufficiency of glottis by means of fumigating licorice extract, improves the symptoms of hoarseness and achieves better therapeutic effect.

聲門閉鎖不全包括單側聲帶麻痺或聲帶萎縮者。 Glottic insufficiency includes unilateral vocal cord paralysis or vocal cord atrophy.

參照第1圖,其係為本發明之甘草萃取液的製備流程示意圖。 Referring to Figure 1, it is a schematic diagram of the preparation process of the licorice extract of the present invention.

在步驟S10中,前處理甘草(Glycyrrhiza)原料以便於進行後續步驟。前處理可選用所屬技術領域中具有通常知識者為習知的任何技術。前處理可包含清洗、浸泡、擠壓、切碎、壓碎、壓輾、研磨、及任何物理性及/或化學 性前處理方式。甘草原料可包含甘草的根部、根狀莖或其組合。此外,甘草原料亦可使用市售之甘草飲片(decocting pieces)。 In step S10, the raw material of licorice (Glycyrrhiza) is pre-treated to facilitate subsequent steps. The pretreatment can be any technique known to those with ordinary knowledge in the technical field. Pretreatment can include washing, soaking, squeezing, chopping, crushing, rolling, grinding, and any physical and/or chemical Sexual pretreatment. The licorice raw material may comprise licorice roots, rhizomes, or a combination thereof. In addition, commercially available licorice decoction pieces (decocting pieces) can also be used as the licorice raw material.

在步驟S20中,將經過前處理之甘草原料進行萃取。萃取步驟可選用所屬技術領域中具有通常知識者為習知的任何技術。萃取步驟可包含攪拌、加熱或超音波震盪等。萃取溶劑可為水或有機溶劑。較佳地,萃取溶劑可為水。此外,萃取可持續地或間隔地進行。在一實施例中,總萃取時間可為60至240分鐘;更佳地為90至120分鐘。在一實施例中,萃取溫度可為80至300度;更佳地為120至180度。在一實施例中,甘草原料與萃取溶劑之重量比例可為1:15至1:35;更佳地為1:20至1:30。在一實施例中,甘草萃取物係為甘草萃取液去除萃取溶劑後的固體產物。在一實施例中,甘草原料的萃取率可利用去除萃取溶劑後之甘草萃取物乾重進行計算,萃取率(%)=萃取後之甘草萃取物乾重/萃取前之甘草原料重量x100%。在一實施例中,甘草原料的甘草萃取物之萃取率可為10%至30%。在另一實施例中,甘草原料的甘草萃取物之萃取率可為10%至50%。在某些實施例中,5g甘草原料可獲得至少0.5g、1g、1.5g、2g、2.5g的甘草萃取物。 In step S20, the pretreated licorice raw material is extracted. The extraction step may be any technique known to those of ordinary skill in the art. The extraction step may include stirring, heating, or sonication, among others. The extraction solvent can be water or an organic solvent. Preferably, the extraction solvent can be water. Furthermore, the extraction is carried out continuously or at intervals. In one embodiment, the total extraction time may be 60 to 240 minutes; more preferably 90 to 120 minutes. In one embodiment, the extraction temperature may be 80 to 300 degrees; more preferably, 120 to 180 degrees. In one embodiment, the weight ratio of the licorice raw material to the extraction solvent may be 1:15 to 1:35; more preferably, 1:20 to 1:30. In one embodiment, the licorice extract is a solid product obtained by removing the extraction solvent from the licorice extract. In one embodiment, the extraction rate of the licorice raw material can be calculated by using the dry weight of the licorice extract after removing the extraction solvent, and the extraction rate (%)=the dry weight of the licorice extract after extraction/the weight of the licorice raw material before extraction×100%. In one embodiment, the extraction rate of the licorice extract of the licorice raw material may be 10% to 30%. In another embodiment, the extraction rate of the licorice extract of the licorice raw material may be 10% to 50%. In certain embodiments, 5 g of licorice raw material can yield at least 0.5 g, 1 g, 1.5 g, 2 g, 2.5 g of licorice extract.

在步驟S30中,將經過萃取步驟之甘草萃取液進行純化,即獲得甘草萃取液(步驟S40)。純化步驟可選用所屬技術領域中具有通常知識者為習知的任何技術。純化步驟可包含沉澱、過濾、離心、管柱層析、薄膜層析或製備級高效液相色譜儀等。 In step S30, the licorice extract that has undergone the extraction step is purified to obtain a licorice extract (step S40). The purification step can be performed by any technique known to those of ordinary skill in the art. Purification steps may include precipitation, filtration, centrifugation, column chromatography, thin film chromatography, or preparative high performance liquid chromatography, and the like.

在一製備例中,係選用甘草飲片作為甘草原料,並利用水作為萃取溶劑;其詳細製備步驟如下:取450g(約120錢)甘草飲片,加入11000c.c.的水進行煎煮,煎煮2小時。一般而言,450g甘草飲片會吸收約2000c.c.的水,因此過 濾甘草飲片後,能夠取得9000c.c.甘草萃取液。而後,將9000c.c.甘草萃取液分為90包,每包為100c.c.甘草萃取液。甘草萃取液內含之甘草萃取物的重量計算如下:經由粗抽,也就是由減壓濃縮機(IKA,德國)抽掉甘草萃取液的所有水分,得到每包100c.c.甘草萃取液的甘草萃取物重量為0.5至1.5g。 In a preparation example, the licorice decoction pieces are selected as the licorice raw material, and water is used as the extraction solvent; the detailed preparation steps are as follows: get 450g (about 120 money) licorice decoction pieces, add 11000c.c. of water for decocting, decocting 2 hours. Generally speaking, 450g licorice pieces will absorb about 2000c.c. After filtering licorice pieces, 9000c.c. licorice extract can be obtained. Then, 9000c.c. licorice extract was divided into 90 packs, each pack was 100c.c. licorice extract. The weight of the licorice extract contained in the licorice extract is calculated as follows: through rough extraction, that is, all the moisture of the licorice extract is removed by a vacuum concentrator (IKA, Germany) to obtain 100 c.c. The licorice extract weighs 0.5 to 1.5 g.

甘草萃取液可以各種方法保存,例如:甘草萃取液可直接封裝保存、將甘草萃取液濃縮至特定保存濃度後封裝保存,或者將甘草萃取液進行乾燥步驟後,以粉體或結晶顆粒型態封裝保存。 The licorice extract can be stored in various ways, for example: the licorice extract can be directly packaged and stored, the licorice extract can be concentrated to a specific storage concentration and then packaged and stored, or the licorice extract can be packaged in the form of powder or crystalline particles after the drying step. save.

乾燥步驟可選用所屬技術領域中具有通常知識者為習知的任何技術。乾燥步驟可包含室溫蒸散、加熱、冷凍乾燥或減壓濃縮等。此外,甘草萃取液可於高溫之無菌狀態下直接封裝,亦可以上述各種型態保存於室溫、冰箱、防潮箱或烘箱中。 The drying step may be any technique known to those of ordinary skill in the art. The drying step may include room temperature evaporation, heating, freeze drying, or concentration under reduced pressure, and the like. In addition, the licorice extract can be directly packaged in a sterile state at high temperature, and can also be stored in the above-mentioned various forms at room temperature, in a refrigerator, a moisture-proof box or an oven.

在一實施例中,以高溫封裝之甘草萃取液可至少放置於室溫或冰箱中長達三個月仍為無菌狀態。 In one embodiment, the licorice extract encapsulated at high temperature can remain sterile for at least three months at room temperature or in a refrigerator.

在一實施例中,粉體或結晶顆粒型態可置於控制環境濕度之環境,以增加其保存時間。 In one embodiment, the powder or crystalline particle form can be placed in an environment with controlled environmental humidity to increase its storage time.

較佳地,本發明之甘草萃取液可保存直至施予前取出,並配置為適於施予之型態。較佳地,保存直至製備為治療聲帶閉鎖不全之藥物前取出,並配置為適於製備之型態。 Preferably, the licorice extract of the present invention can be stored until taken out before administration, and configured in a form suitable for administration. Preferably, it is stored until it is taken out before being prepared as a drug for treating insufficiency of vocal cords, and is configured into a form suitable for preparation.

在一實施例中,施予預定劑量的甘草萃取液至目標物之鼻部。目標物可為哺乳類動物,例如:人類、牛、羊、豬、狗、貓、馬、驢、兔等。 In one embodiment, a predetermined dose of licorice extract is administered to the nose of the target. The target can be mammals, such as humans, cows, sheep, pigs, dogs, cats, horses, donkeys, rabbits, and the like.

在一實施例中,施予本發明之用於製備治療聲帶閉鎖不全藥物之途徑係為吸入式授藥(inhalation administration)。在一實施例中,施予本發明之用 於製備治療聲帶閉鎖不全藥物之途徑係為口鼻吸入(mouth and nose inhalation)方式。 In one embodiment, the route of administering the medicament for the treatment of vocal cord insufficiency of the present invention is inhalation administration. In one embodiment, the use of the present invention is administered The route for preparing the medicament for the treatment of vocal cord insufficiency is mouth and nose inhalation.

在一實施例中,可使用市售可產生霧化之薰蒸機器,將甘草萃取液溫熱後倒入薰蒸機器中,使其產生噴霧,再請患者帶上面罩以口或鼻吸入其噴霧至喉嚨,進行聲門閉鎖不全之治療。 In one embodiment, a commercially available fumigation machine that can generate atomization can be used, the licorice extract is warmed and then poured into the fumigation machine to generate a spray, and then the patient is asked to wear a mask and inhale it through the mouth or nose. Spray to the throat for the treatment of glottis insufficiency.

在一實施例中,進行薰蒸治療之頻率為每周1至3次;更佳地,每周至少3至5次;更佳地,每日至少1至3次。 In one embodiment, the frequency of fumigation treatment is 1 to 3 times a week; more preferably, at least 3 to 5 times a week; more preferably, at least 1 to 3 times a day.

在一實施例中,使用甘草萃取液進行薰蒸治療時,每次薰蒸時間至少5至30分鐘;更佳地,每次薰蒸時間至少10至20分鐘。 In one embodiment, when using licorice extract for fumigation treatment, each fumigation time is at least 5 to 30 minutes; more preferably, each fumigation time is at least 10 to 20 minutes.

甘草萃取液之使用功效: 以病患語音障礙問卷(Voice Handicap Index-10,VHI-10),讓病患自我評估語言障礙,其分數越高表示嗓音問題越嚴重。一般嗓音障礙之分數層級如下所述:0~5分為正常,6~10分為輕度,11~20分為中度,21~40則為重度。 The use of licorice extract: Using the Patient Voice Handicap Index-10 (VHI-10), the patients were asked to self-assess their language barriers. The higher the score, the more serious the voice problem. Generally speaking, the score level of voice disorder is as follows: 0-5 is normal, 6-10 is mild, 11-20 is moderate, and 21-40 is severe.

參考第2圖,其為搭配甘草萃取液之中醫藥治療之6位患者在治療前後的VHI-10差異。接受搭配甘草萃取液中醫藥治療之患者治療時間從半個月至半年不等,平均治療時間為3~4個月。結果顯示,治療前VHI-10之平均值為22.0分(標準差為7.5),而在治療後VHI-10之平均值下降至11.8分(標準差為7.0,P=0.03)。 Referring to Figure 2, it is the difference of VHI-10 before and after treatment of 6 patients treated with Chinese medicine with licorice extract. The treatment time of patients receiving traditional Chinese medicine treatment with licorice extract varies from half a month to half a year, with an average treatment time of 3 to 4 months. The results showed that the mean value of VHI-10 before treatment was 22.0 points (standard deviation: 7.5), and the mean value of VHI-10 decreased to 11.8 points (standard deviation: 7.0, P=0.03) after treatment.

由上述第2圖所展示之治療前後VHI-10分數的差異中可看出,搭配本案之甘草萃取液進行中醫藥治療的患者,其嗓音進步程度皆顯著提升,代表使用甘草萃取液的確具有明顯的治療功效。 From the difference in VHI-10 scores before and after treatment shown in Figure 2 above, it can be seen that the patients treated with traditional Chinese medicine with the licorice extract in this case have significantly improved their voice, which means that the use of licorice extract does have a significant effect. therapeutic efficacy.

參考第3圖,其為搭配甘草萃取液之中醫藥治療之5位患者在治療前後的VHI-10差異。同上所述,其接受治療之患者治療時間從半個月至半年不等,平均治療時間為3~4個月。治療前VHI-10之平均值為27.4分(標準差為7.2),而在治療後VHI-10之平均值下降至4.6分(標準差為5.5,P=0.04),VHI-10平均值下降22.8(約80%)。 Referring to Figure 3, it is the difference in VHI-10 before and after treatment of 5 patients treated with traditional Chinese medicine with licorice extract. As mentioned above, the treatment time of the patients receiving treatment varies from half a month to half a year, with an average treatment time of 3 to 4 months. The mean of VHI-10 before treatment was 27.4 points (standard deviation: 7.2), and the mean VHI-10 decreased to 4.6 points (standard deviation: 5.5, P=0.04) after treatment, and the mean VHI-10 decreased by 22.8 (about 80%).

參考第4a圖及第4b圖,其分別為聲帶麻痺患者以喉閃爍攝影觀察搭配甘草萃取液之中醫藥治療前及治療後之聲帶示意圖,搭配甘草萃取液之中醫藥治療時間約為3個月。第4a圖為治療前之聲帶,可看出聲帶兩側之肌肉有萎縮的現象,而經由搭配甘草萃取液之中醫藥治療後,可由第4b圖中看出聲帶兩側之肌肉明顯復原許多,且患者之嗓音也明顯好轉,沙啞之現象改善許多,故使用甘草萃取液搭配中醫藥的確具有明顯的治療功效。 Referring to Figure 4a and Figure 4b, they are respectively a schematic diagram of the vocal cords before and after treatment with licorice extract and Chinese medicine for a patient with vocal cord paralysis using laryngeal scintigraphy. The treatment time with licorice extract and Chinese medicine is about 3 months. . Figure 4a shows the vocal cords before the treatment. It can be seen that the muscles on both sides of the vocal cords have atrophied. After the treatment with Chinese medicine with licorice extract, it can be seen from Figure 4b that the muscles on both sides of the vocal cords have recovered a lot. In addition, the patient's voice has also improved significantly, and the hoarseness has improved a lot. Therefore, the use of licorice extract in combination with traditional Chinese medicine does have obvious therapeutic effects.

Claims (5)

一種甘草萃取液用於製備治療聲帶閉鎖不全之藥物的用途,其包含:施予一甘草(Glycyrrhiza)萃取液於一目標物喉部,其中該甘草萃取液係以水溶液萃取而得。 A use of a licorice extract for preparing a medicine for treating vocal cord insufficiency, comprising: administering a licorice (Glycyrrhiza) extract to the throat of a target, wherein the licorice extract is obtained by extracting an aqueous solution. 如請求項1所述之用途,其中施予該藥物之途徑係將該甘草萃取液霧化後,以口或鼻呼吸之方式投予至喉部。 The use according to claim 1, wherein the route of administering the drug is after the licorice extract is atomized, and then administered to the throat by means of oral or nasal breathing. 如請求項1所述之用途,其中該聲帶閉鎖不全係由聲帶萎縮或聲帶麻痺所造成。 The use of claim 1, wherein the atresia of the vocal cords is caused by vocal cord atrophy or vocal cord paralysis. 如請求項1所述之用途,其中每100c.c該甘草萃取液中包含0.1g至10g的甘草萃取物。 The use according to claim 1, wherein every 100 c.c of the licorice extract contains 0.1 g to 10 g of the licorice extract. 如請求項1所述之用途,進一步包含一中醫藥。 The use according to claim 1 further comprises a traditional Chinese medicine.
TW109127683A 2020-08-14 2020-08-14 Use of glycyrrhiza extract in preparation of medicament for treating glottic insufficiency with inhalation TWI757830B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW109127683A TWI757830B (en) 2020-08-14 2020-08-14 Use of glycyrrhiza extract in preparation of medicament for treating glottic insufficiency with inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109127683A TWI757830B (en) 2020-08-14 2020-08-14 Use of glycyrrhiza extract in preparation of medicament for treating glottic insufficiency with inhalation

Publications (2)

Publication Number Publication Date
TW202206091A TW202206091A (en) 2022-02-16
TWI757830B true TWI757830B (en) 2022-03-11

Family

ID=81323759

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109127683A TWI757830B (en) 2020-08-14 2020-08-14 Use of glycyrrhiza extract in preparation of medicament for treating glottic insufficiency with inhalation

Country Status (1)

Country Link
TW (1) TWI757830B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200607519A (en) * 2004-08-19 2006-03-01 Cang-Qi Chang A kind of mouth cavity aims at various ragged and the throat pain provide the curative effect and put on of chinese herbal medicine
TW200808333A (en) * 2006-04-17 2008-02-16 Kaneka Corp Licorice polyphenol preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200607519A (en) * 2004-08-19 2006-03-01 Cang-Qi Chang A kind of mouth cavity aims at various ragged and the throat pain provide the curative effect and put on of chinese herbal medicine
TW200808333A (en) * 2006-04-17 2008-02-16 Kaneka Corp Licorice polyphenol preparation

Also Published As

Publication number Publication date
TW202206091A (en) 2022-02-16

Similar Documents

Publication Publication Date Title
CN113812672B (en) Electronic cigarette tobacco tar containing sodium hyaluronate and preparation method thereof
CN103263529B (en) Traditional Chinese medicine composition for treating bone fracture
TWI757830B (en) Use of glycyrrhiza extract in preparation of medicament for treating glottic insufficiency with inhalation
CN105055518A (en) Traditional Chinese medicine fumigant for treating child rhinitis
CN104958429A (en) Traditional Chinese medicinal composition for treating geriatric fracture and preparation method thereof
CN113925920A (en) Traditional Chinese medicine atomized liquid for treating chronic pharyngitis and preparation method and application thereof
CN102671036B (en) Traditional Chinese medicine oral liquid for treating chronic lung abscess and preparing method thereof
CN106344772A (en) traditional Chinese medicine composition for treating rhinitis, external preparation and preparation method thereof
Afreen et al. Therapeutic uses of earthworm–a review
CN104873723B (en) A kind of burn-scald medicine containing cinnamon oil
CN111388617B (en) Traditional Chinese medicine composition for eliminating phlegm and relieving cough and preparation method thereof
CN107233406A (en) A kind of traditional Chinese medicine for outer use for treating hormone face
CN114470110B (en) Anti-rhinitis traditional Chinese medicine composition with pain relieving effect
CN107519473A (en) One kind moistens the lung and relieve the cough composition and preparation method thereof
CN105920354A (en) Throat inhalant for treating bronchiectasia
CN106620160A (en) Traditional Chinese medicine composition for treating bone fracture and preparation method of traditional Chinese medicine composition
CN107913331A (en) A kind of Chinese and Western medicine compound preparation for treating acute epiglottitis and preparation method
CN118161575A (en) Nasal inhalation traditional Chinese medicine fermentation probiotic aerosol for treating rhinitis
CN105477625A (en) Dust adsorption and removal Chinese herbal medicine preparation and preparation method thereof
WO2022258722A1 (en) Composition comprising centella extract and hippophae extract
CN115919945A (en) Preparation method and application of traditional Chinese medicine oral-nasal atomized antiviral and antibacterial liquid
CA3223310A1 (en) Use of traditional chinese medicine composition in preparation of drug for treating cough variant asthma
KR20230046905A (en) Respiratory Disease Treatment
CN116098947A (en) Preparation process of compound sea snake combined preparation
CN116870055A (en) Traditional Chinese medicine composition for treating herpes zoster and preparation method thereof